Close Menu

Tech Review highlights a test from Adnavance that can detect methicillin-resistant Staphylococcus aureus without culturing the bacteria or amplifying the DNA. Instead, the Adnavance test is built on top of a gold electrode that is covered with a proprietary marker. The marker binds MRSA and when a current flows through the gold electrode, it attracts the DNA. CEO Randy White says they plan to launch the test in 2011 at a price of about $60.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.